Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.

about

Corrigendum: Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.

P921

Q42345736-1934A8F1-0A4E-448D-BAEA-F4CC4C215F32

P921

Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.

Item

http://www.wikidata.org/entity/Q41931096

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.

@en

type

Item

label

Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.

@en

prefLabel

Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.

@en

P1476

Melatonin and Nitrones As Potential Therapeutic Agents for Stroke

@en

P2093

Alberto Alcázar

http://www.w3.org/2001/XMLSchema#string

Eva Ramos

http://www.w3.org/2001/XMLSchema#string

Francisco López-Muñoz

http://www.w3.org/2001/XMLSchema#string

José Marco-Contelles

http://www.w3.org/2001/XMLSchema#string

María I Ayuso

http://www.w3.org/2001/XMLSchema#string

Paloma Patiño

http://www.w3.org/2001/XMLSchema#string

P2507

Corrigendum: Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.

P2860

Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease

Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia

Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins

Melatonin attenuates the focal cerebral ischemic injury by inhibiting the dissociation of pBad from 14-3-3

Regulatory proteins of eukaryotic initiation factor 2-alpha subunit (eIF2 alpha) phosphatase, under ischemic reperfusion and tolerance

Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions

Nitrones as therapeutics.

Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia.

Melatonin reduces disseminate neuronal death after mild focal ischemia in mice via inhibition of caspase-3 and is suitable as an add-on treatment to tissue-plasminogen activator.

Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme-1.

P304

281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNAGI.2016.00281

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alejandro Romero Martínez

M J Oset-Gasque

P577

2016-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27932976

http://www.w3.org/2001/XMLSchema#string

P932

5120103

http://www.w3.org/2001/XMLSchema#string

Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.

about

P921

P921

Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2507

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2507

P2860

P304

P31

P356

P478

P50

P577

P698

P932